Sangamo Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

Name: Sangamo Therapeutics Inc: Is Infosys Ltd. worth buying?
Item: Sangamo Therapeutics Inc
Rating: 1.20400
Author: Trendlyne DVM scores

about

Sangamo Therapeutics Inc is a genomic medicine company committed to translating ground-breaking science into medicines that transform the lives of patients and families afflicted with serious neurological diseases. Its pipeline products include the P...

0.45 -0.01 (-2.17%)

84.15% Fall from 52W High

4.4M

XNAS Volume

XNAS 12 Dec, 2025 4:30 PM (EST)

Not Eligible

Expensive Valuation

12.0 / 100

Technically Neutral

36.2 / 100

1Yr Price target upside is 622%

5 analysts

Sangamo Therapeutics Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Sangamo Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

Sangamo Therapeutics Inc is a genomic medicine company committed to translating ground-breaking science into medicines that transform the lives of patients and families afflicted with serious neurological diseases. Its pipeline products include the P...

84.15% Fall from 52W High

SWOT Analysis

Sangamo Therapeutics Inc Live Price Chart